Cearvol Wave vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Cearvol Wave
The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. The Wave's standout performance is in music streaming, where it scores a strong 4.1/5—a full 2.18 points above the OTC category average. This makes it an unusually capable choice for users who prioritize audio entertainment alongside speech amplification. Speech performance is solid in quiet environments at 3.1/5, sitting 0.36 points above the category average. Speech in noise presents a more mixed picture: while the 2.0/5 score exceeds the category average by 0.56 points, it remains modest in absolute terms—typical of OTC devices without advanced noise management. Own-voice comfort scores 2.1/5, falling 0.41 points below average, which may be noticeable during extended wear. Feedback handling is solid at 3.8/5, though 0.74 points below the category average. The Cearvol Wave is best suited for budget-conscious consumers who want capable music streaming and adequate speech clarity in quieter settings. Those frequently in noisy environments or sensitive to own-voice quality may want to consider alternatives with stronger performance in those areas.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit